STA Pharmaceutical Hong Kong Investment, the shareholder of WUXI XDC (02268.HK) 0.000 (0.000%) Short selling $1.70M; Ratio 2.675% , placed 37.8 million shares of the company at $3 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Amidst recent fluctuations in global markets, driven by tariff uncertainties and mixed economic data, investors are seeking opportunities that might be overlooked. In this environment, identifying ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are ...

We've identified the following companies as similar to WuXi XDC Cayman Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to ...

A Aaaaaaaaa A 113.32 +22.98% ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Identifying such undervalued stocks... WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.